Dr. Daniel Fred Goodman, MD

Dr. Goodman practices at Daniel F Goodman MD in San Francisco, California.

Dr. Goodman's NPI, 1679758635, was assigned on January 8, 2008. Dr. Goodman graduated from University Of Michigan Medical School in 1980. Dr. Goodman holds California license G53124.

Dr. Goodman's primary practice is Daniel F Goodman MD, at 2211 Bush St, San Francisco, CA 94115 in San Francisco County. The practice phone is (415) 474-3333.

Dr. Goodman's primary practice is Daniel F Goodman MD in San Francisco, California. Dr. Goodman is also affiliated with California Pacific Medical Center Van Ness Campus. Dmand AI also links Dr. Goodman to 1 more hospital, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Goodman practices, 3 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Goodman's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Goodman is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Goodman's licenses on file in 2 states: California and Maryland.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, cold sores or genital herpes, conjunctivitis, dry eye, eye infection or inflammation and eyelid inflammation among the conditions Dr. Goodman treats.

CMS data shows 4,653 Medicare services from Dr. Goodman across 15 procedure codes in 2024, for 1,379 Medicare patients. Medicare paid $455,695 for them.

CMS counts 1,379 Medicare patients who saw Dr. Goodman in 2024. The largest group is 75 to 84, with 657 patients. 71% of them have high cholesterol, and 57% have high blood pressure. 5% are also on Medicaid. Their average risk score is 0.88, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Goodman's median patient age at 68, with 53% women.

In 2024, Dr. Goodman wrote 580 Medicare Part D claims for 203 patients. 43% of them were for generic drugs. CMS names the drug for 427 of them, across 11 drugs with 11 or more claims each, at $94,842 in total drug cost. In 2023, CMS named 529 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Goodman for performance year 2024, reported as part of a group. Dr. Goodman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 323 procedures of cataract surgery by Dr. Goodman, more than 90% of the clinicians it reports for that procedure.

Dmand AI links 22 papers to Dr. Goodman, published from 2010 to 2011. 2011 was the busiest year, with 3. The most frequent topics are Visual Acuity, Cornea and Postoperative Complications. Dr. Goodman has published most often in Arch Ophthalmol. Dr. Goodman's most frequent co-authors are Alejandra Gabriela De Alba Campomanes, MD, MPH, Jonathan Ezra Hodes, MD and Richard Imes, MD.

Dmand AI links Dr. Goodman to 1 clinical trial. Conditions studied include Dilatation, Pathologic and Keratoconus.

CMS Open Payments shows 209 general payments to Dr. Goodman from 36 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 90% of the total. Alcon Laboratories Inc paid the most, $1,405.

Dmand AI lists 3 awards for Dr. Goodman, most recently Regional Top Doctor in 2022.

Dr. Goodman graduated from University Of Michigan Medical School in 1980. Dr. Goodman is a member of AAO and ACS.

Dr. Goodman is in network with 15 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.